Role of Alix in miRNA packaging during extracellular vesicle biogenesis

International Journal of Molecular Medicine

Volumn 37, Issue 4, 2016, Pages 958-966

  Iavello, Alessandra ^a   Frech, Valeska S L ^a   Gai, Chiara ^a   Deregibus, Maria Chiara ^a   Quesenberry, Peter J ^b   Camussi, Giovanni ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b BROWN UNIVERSITY   (United States)

Author keywords

Alix; Argonaute 2; Exosomes; MicroRNAs; Microvesicles

Indexed keywords

ALIX; ARGONAUTE 2 PROTEIN; MICRORNA; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; ARGONAUTE PROTEIN; CALCIUM BINDING PROTEIN; CELL CYCLE PROTEIN; EIF2C2 PROTEIN, HUMAN; ESCRT PROTEIN; PDCD6IP PROTEIN, HUMAN;

ARTICLE; BIOGENESIS; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; EXOSOME; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA STRUCTURE; CELL LINE; CYTOLOGY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; LIVER; LIVER CELL; METABOLISM; STEM CELL; UMBILICAL VEIN ENDOTHELIAL CELL;

ARGONAUTE PROTEINS; CALCIUM-BINDING PROTEINS; CELL CYCLE PROTEINS; CELL LINE; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; EXTRACELLULAR VESICLES; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HEPATOCYTES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOPRECIPITATION; LIVER; MICRORNAS; STEM CELLS;

EID: 84960540417     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2016.2488     Document Type: Article

References (52)

1. Quesenberry PJ, Goldberg LR, Aliotta JM, Dooner MS, Pereira MG, Wen S and Camussi G: Cellular phenotype and extracellular vesicles: basic and clinical considerations. Stem Cells Dev 23: 1429-1436, 2014.
2. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A and Ratajczak MZ: Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20: 1487-1495, 2006.
3. Théry C, Ostrowski M and Segura E: Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9: 581-593, 2009.
4. Lee TH, D'Asti E, Magnus N, Al-Nedawi K, Meehan B and Rak J: Microvesicles as mediators of intercellular communication in cancer - the emerging science of cellular 'debris'. Semin Immunopathol 33: 455-467, 2011.
5. Cocucci E, Racchetti G and Meldolesi J: Shedding microvesicles: artefacts no more. Trends Cell Biol 19: 43-51, 2009.
6. Colombo M, Raposo G and Théry C: Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30: 255-289, 2014.
7. Gould SJ and Raposo G: As we wait: coping with an imperfect nomenclature for extracellular vesicles. J Extracell Vesicles 2: Feb 15, 2013 (Epub ahead of print). doi: 10.3402/jev.v2i0.20389.
8. Chen X, Liang H, Zhang J, Zen K and Zhang CY: Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol 22: 125-132, 2012.
9. Wang K, Zhang S, Weber J, Baxter D and Galas DJ: Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 38: 7248-7259, 2010.
10. Gallo A, Tandon M, Alevizos I and Illei GG: The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 7: e30679, 2012.
11. Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P and Ratajczak MZ: Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20: 847-856, 2006.
12. Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, Biancone L, Bruno S, Bussolati B and Camussi G: Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110: 2440-2448, 2007.
13. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659, 2007.
14. Collino F, Deregibus MC, Bruno S, Sterpone L, Aghemo G, Viltono L, Tetta C and Camussi G: Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One 5: e11803, 2010.
15. Aliotta JM, Sanchez-Guijo FM, Dooner GJ, Johnson KW, Dooner MS, Greer KA, Greer D, Pimentel J, Kolankiewicz LM, Puente N, et al: Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation. Stem Cells 25: 2245-2256, 2007.
16. Gibbings D, Leblanc P, Jay F, Pontier D, Michel F, Schwab Y, Alais S, Lagrange T and Voinnet O: Human prion protein binds Argonaute and promotes accumulation of microRNA effector complexes. Nat Struct Mol Biol 19: 517-524, S1, 2012.
17. Laver JD, Li X, Ancevicius K, Westwood JT, Smibert CA, Morris QD and Lipshitz HD: Genome-wide analysis of Staufen-associated mRNAs identifies secondary structures that confer target specificity. Nucleic Acids Res 41: 9438-9460, 2013.
18. Waris S, Wilce MC and Wilce JA: RNA recognition and stress granule formation by TIA proteins. Int J Mol Sci 15: 23377-23388, 2014.
19. Höck J and Meister G: The Argonaute protein family. Genome Biol 9: 210, 2008.
20. Herrera MB, Fonsato V, Bruno S, Grange C, Gilbo N, Romagnoli R, Tetta C and Camussi G: Human liver stem cells improve liver injury in a model of fulminant liver failure. Hepatology 57: 311-319, 2013.
21. Herrera MB, Fonsato V, Gatti S, Deregibus MC, Sordi A, Cantarella D, Calogero R, Bussolati B, Tetta C and Camussi G: Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med 14: 1605-1618, 2010.
22. Herrera MB, Bruno S, Buttiglieri S, Tetta C, Gatti S, Deregibus MC, Bussolati B and Camussi G: Isolation and characterization of a stem cell population from adult human liver. Stem Cells 24: 2840-2850, 2006.
23. Fonsato V, Collino F, Herrera MB, Cavallari C, Deregibus MC, Cisterna B, Bruno S, Romagnoli R, Salizzoni M, Tetta C and Camussi G: Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs. Stem cells 30:1985-1998, 2012.
24. Martin-Serrano J, Yarovoy A, Perez-Caballero D and Bieniasz PD: Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc Natl Acad Sci USA 100: 12414-12419, 2003.
25. Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, Ivarsson Y, Depoortere F, Coomans C, Vermeiren E, et al: Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 14: 677-685, 2012.
26. Roucourt B, Meeussen S, Bao J, Zimmermann P and David G: Heparanase activates the syndecan-syntenin-ALIX exosome pathway. Cell Res 25: 412-428, 2015.
27. Ghossoub R, Lembo F, Rubio A, Gaillard CB, Bouchet J, Vitale N, Slavík J, Machala M and Zimmermann P: Syntenin-ALIX exosome biogenesis and budding into multivesicular bodies are controlled by ARF6 and PLD2. Nat Commun 5: 3477, 2014.
28. Missotten M, Nichols A, Rieger K and Sadoul R: Alix, a novel mouse protein undergoing calcium-dependent interaction with the apoptosis-linked-gene 2 (ALG-2) protein. Cell Death Differ 6: 124-129, 1999.
29. Odorizzi G, Katzmann DJ, Babst M, Audhya A and Emr SD: Bro1 is an endosome-associated protein that functions in the MVB pathway in Saccharomyces cerevisiae. J Cell Sci 116: 1893-1903, 2003.
30. Schmidt MH, Hoeller D, Yu J, Furnari FB, Cavenee WK, Dikic I and Bögler O: Alix/AIP1 antagonizes epidermal growth factor receptor downregulation by the Cbl-SETA/CIN85 complex. Mol Cell Biol 24: 8981-8993, 2004.
31. Strack B, Calistri A, Craig S, Popova E and Göttlinger HG: AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 114: 689-699, 2003.
32. Sette P, Dussupt V and Bouamr F: Identification of the HIV-1 NC binding interface in Alix Bro1 reveals a role for RNA. J Virol 86: 11608-11615, 2012.
33. Morita E, Sandrin V, Chung HY, Morham SG, Gygi SP, Rodesch CK and Sundquist WI: Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis. EMBO J 26: 4215-4227, 2007.
34. Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJ, Hole P, Carr B, Redman CW, Harris AL, Dobson PJ, et al: Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine 7: 780-788, 2011.
35. Lopatina T, Bruno S, Tetta C, Kalinina N, Porta M and Camussi G: Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential. Cell Commun Signal 12: 26, 2014.
36. Deregibus MC, Buttiglieri S, Russo S, Bussolati B and Camussi G: CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis. J Biol Chem 278: 18008-18014, 2003.
37. Anderson P and Kedersha N: RNA granules. J Cell Biol 172: 803-808, 2006.
38. Lin J, Li J, Huang B, Liu J, Chen X, Chen XM, Xu YM, Huang LF and Wang XZ: Exosomes: novel biomarkers for clinical diagnosis. ScientificWorldJournal 2015: 657086, 2015.
39. Katoh M: Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks (Review). Int J Mol Med 32: 763-767, 2013.
40. Chaput N and Théry C: Exosomes: Immune properties and potential clinical implementations. Semin Immunopathol 33: 419-440, 2011.
41. Milane L, Singh A, Mattheolabakis G, Suresh M and Amiji MM: Exosome mediated communication within the tumor microenvironment. J Control Release 219: 278-294, 2015.
42. De Jong OG, Van Balkom BW, Schiffelers RM, Bouten CV and Verhaar MC: Extracellular vesicles: potential roles in regenerative medicine. Front Immunol 5: 608, 2014.
43. Quesenberry PJ, Aliotta J, Deregibus MC and Camussi G: Role of extracellular RNA-carrying vesicles in cell differentiation and reprogramming. Stem Cell Res Ther 6: 153, 2015.
44. Zhang Y, Wu XH, Luo CL, Zhang JM, He BC and Chen G: Interleukin-12-anchored exosomes increase cytotoxicity of T lymphocytes by reversing the JAK/STAT pathway impaired by tumor-derived exosomes. Int J Mol Med 25: 695-700, 2010.
45. Morita E: Differential requirements of mammalian ESCRTs in multivesicular body formation, virus budding and cell division. FEBS J 279: 1399-1406, 2012.
46. Roxrud I, Stenmark H and Malerød L: ESCRT & Co. Biol Cell 102: 293-318, 2010.
47. Votteler J and Sundquist WI: Virus budding and the ESCRT pathway. Cell Host Microbe 14: 232-241, 2013.
48. Pan S, Wang R, Zhou X, He G, Koomen J, Kobayashi R, Sun L, Corvera J, Gallick GE and Kuang J: Involvement of the conserved adaptor protein Alix in actin cytoskeleton assembly. J Biol Chem 281: 34640-34650, 2006.
49. Shen B, Wu N, Yang JM and Gould SJ: Protein targeting to exosomes/microvesicles by plasma membrane anchors. J Biol Chem 286: 14383-14395, 2011.
50. Fang Y, Wu N, Gan X, Yan W, Morrell JC and Gould SJ: Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes. PLoS Biol 5: e158, 2007.
51. Booth AM, Fang Y, Fallon JK, Yang JM, Hildreth JE and Gould SJ: Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane. J Cell Biol 172: 923-935, 2006.
52. Li L, Zhu D, Huang L, Zhang J, Bian Z, Chen X, Liu Y, Zhang CY and Zen K: Argonaute 2 complexes selectively protect the circulating microRNAs in cell-secreted microvesicles. PLoS One 7: e46957, 2012.